Transient Hyperglycaemia In Premature Infants clinical trials

Explore recruiting transient hyperglycaemia in premature infants clinical trials.

Also recruiting in Europe

Transient Hyperglycaemia In Premature Infants trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

GALOP: Oral Glibenclamide in premature hyperglycemia

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Transient Hyperglycaemia In Premature Infants trials by city

Transient Hyperglycaemia In Premature Infants in Toronto Transient Hyperglycaemia In Premature Infants in Vancouver Transient Hyperglycaemia In Premature Infants in Montreal Transient Hyperglycaemia In Premature Infants in Calgary Transient Hyperglycaemia In Premature Infants in Edmonton Transient Hyperglycaemia In Premature Infants in Ottawa Transient Hyperglycaemia In Premature Infants in Winnipeg Transient Hyperglycaemia In Premature Infants in Quebec City Transient Hyperglycaemia In Premature Infants in Hamilton Transient Hyperglycaemia In Premature Infants in Kitchener Transient Hyperglycaemia In Premature Infants in London Transient Hyperglycaemia In Premature Infants in Halifax Transient Hyperglycaemia In Premature Infants in New York Transient Hyperglycaemia In Premature Infants in Los Angeles Transient Hyperglycaemia In Premature Infants in Chicago Transient Hyperglycaemia In Premature Infants in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease